Publications by authors named "Yuying Hwang"

Claim this Profile
P
Phase I Study of AMG 337, a Highly Selective Small-molecule MET Inhibitor, in Patients with Advanced Solid Tumors.
David S Hong, Patricia LoRusso, Omid Hamid, Filip Janku, Muaiad Kittaneh, Yuying C Hwang

Clin Cancer Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I, First-in-Human Study of AMG 780, an Angiopoietin-1 and -2 Inhibitor, in Patients with Advanced Solid Tumors.
Afshin Dowlati, Gordana Vlahovic, Ronald B Natale, Erik Rasmussen, Indrajeet Singh, Yuying C Hwang

Clin Cancer Res· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A first-in-human study of AMG 208, an oral MET inhibitor, in adult patients with advanced solid tumors.
David S Hong, Peter Rosen, A Craig Lockhart, Siqing Fu, Filip Janku, Yuying C Hwang

Oncotarget· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and pharmacokinetics of ganitumab (AMG 479) combined with sorafenib, panitumumab, erlotinib, or gemcitabine in patients with advanced solid tumors.
Lee S Rosen, Igor Puzanov, Gregory Friberg, Emily Chan, Yuying C Hwang

Clin Cancer Res· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A first-in-human study of conatumumab in adult patients with advanced solid tumors.
Roy S Herbst, Razelle Kurzrock, David S Hong, Manuel Valdivieso, Cheng-Pang Hsu, Yuying C Hwang

Clin Cancer Res· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors.
Roy S Herbst, David Hong, Linnea Chap, Razelle Kurzrock, Edward Jackson, Yuying C Hwang

J Clin Oncol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore.
Radha Ananthakrishnan, Michiyo Kaneko, Yuying C Hwang, Nosirudeen Quadri, Teodoro Gomez

Am J Physiol Heart Circ Physiol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polyol pathway and modulation of ischemia-reperfusion injury in Type 2 diabetic BBZ rat hearts.
Qing Li, Yuying C Hwang, Radha Ananthakrishnan, Peter J Oates, Dennis Guberski

Cardiovasc Diabetol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAGE and modulation of ischemic injury in the diabetic myocardium.
Loredana G Bucciarelli, Radha Ananthakrishnan, Yuying C Hwang, Michiyo Kaneko, Fei Song

Diabetes· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo DA D(1) receptor selectivity of NNC 112 and SCH 23390.
Jesper Ekelund, Mark Slifstein, Raj Narendran, Olivier Guillin, Hemant Belani, Yuying Hwang, Dah-Ren Hwang

Mol Imaging Biol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amphetamine-induced dopamine release: duration of action as assessed with the D2/3 receptor agonist radiotracer (-)-N-[(11)C]propyl-norapomorphine ([11C]NPA) in an anesthetized nonhuman primate.
Rajesh Narendran, Mark Slifstein, Dah-Ren Hwang, Yuying Hwang, Erica Scher

Synapse· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
Rajesh Narendran, Mark Slifstein, Olivier Guillin, Yuying Hwang, Dah-Ren Hwang

Synapse· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Receptor for advanced-glycation end products: key modulator of myocardial ischemic injury.
Loredana G Bucciarelli, Michiyo Kaneko, Radha Ananthakrishnan, Evis Harja, Larisse K Lee, Yuying C Hwang

Circulation· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement of the proportion of D2 receptors configured in state of high affinity for agonists in vivo: a positron emission tomography study using [11C]N-propyl-norapomorphine and [11C]raclopride in baboons.
Rajesh Narendran, Dah-Ren Hwang, Mark Slifstein, Yuying Hwang, Yiyun Huang

J Pharmacol Exp Ther· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perfusion of hearts with triglyceride-rich particles reproduces the metabolic abnormalities in lipotoxic cardiomyopathy.
Priya Pillutla, Yuying C Hwang, Ayanna Augustus, Masayoshi Yokoyama, Hiroaki Yagyu

Am J Physiol Endocrinol Metab· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aldose reductase and AGE-RAGE pathways: key players in myocardial ischemic injury.
Michiyo Kaneko, Loredana Bucciarelli, Yuying C Hwang, Larisee Lee, Shi Fang Yan

Ann N Y Acad Sci· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aldose reductase pathway mediates JAK-STAT signaling: a novel axis in myocardial ischemic injury.
Yuying C Hwang, Sean Shaw, Michiyo Kaneko, Heather Redd, Mario B Marrero

FASEB J· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central role for aldose reductase pathway in myocardial ischemic injury.
Yuying C Hwang, Michiyo Kaneko, Soliman Bakr, Hui Liao, Yan Lu

FASEB J· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic and functional protection by selective inhibition of nitric oxide synthase 2 during ischemia-reperfusion in isolated perfused hearts.
Ravichandran Ramasamy, Yuying C Hwang, Yulin Liu, Ni Huiping Son, Ningsheng Ma

Circulation· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorbitol dehydrogenase: a novel target for adjunctive protection of ischemic myocardium.
Yuying C Hwang, Soliman Bakr, Craig A Ellery, Peter J Oates, Ravichandran Ramasamy

FASEB J· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and initial evaluation of 17-(11)C-heptadecanoic acid for measurement of myocardial fatty acid metabolism.
T Lee Collier, Yuying Hwang, Ravichandran Ramasamy, Robert R Sciacca, Kathleen T Hickey

J Nucl Med· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative importance of enhanced glucose uptake versus attenuation of long-chain acyl carnitines in protecting ischemic myocardium.
Yuying C Hwang, Soliman Bakr, Ravichandran Ramasamy, Steven R Bergmann

Coron Artery Dis· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aldose reductase activation is a key component of myocardial response to ischemia.
Yuying C Hwang, Sanai Sato, Jen-Yue Tsai, ShiDu Yan, Soliman Bakr

FASEB J· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis